We are live on ! Find out more
DDC

Daniel Devine & Co Portfolio holdings

AUM $125M
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$8.27M
Cap. Flow
+$2.55M
Cap. Flow %
1.95%
Top 10 Hldgs %
69.45%
Holding
51
New
4
Increased
3
Reduced
13
Closed
2

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.64M
2
COST icon
Costco
COST
+$1.58M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$414K
4
IOO icon
iShares Global 100 ETF
IOO
+$382K
5
IBB icon
iShares Biotechnology ETF
IBB
+$266K

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$399K
2
PAA icon
Plains All American Pipeline
PAA
+$231K
3
EXPD icon
Expeditors International
EXPD
+$226K
4
BPL
Buckeye Partners, L.P.
BPL
+$205K
5
JNJ icon
Johnson & Johnson
JNJ
+$106K

Sector Composition

Rank Sector Weight
1 Healthcare 12.49%
2 Financials 7.03%
3 Technology 6.54%
4 Industrials 3.7%
5 Energy 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$30.6M 23.42%
121,977
+145
+0.1% +$35.7K
QQQ icon
2
Invesco QQQ Trust
QQQ
$453B
$16.8M 12.85%
115,630
– –
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$15.2M 11.63%
46,615
– –
AAPL icon
4
Apple
AAPL
$4.54T
$7.49M 5.72%
194,252
-2,000
-1% -$77.6K
IBB icon
5
iShares Biotechnology ETF
IBB
$9.34B
$4.74M 3.62%
42,585
+2,490
+6% +$266K
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$4.73M 3.62%
36,407
-800
-2% -$106K
EEM icon
7
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.07M 2.35%
68,600
– –
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.88M 2.2%
15,700
– –
ABBV icon
9
AbbVie
ABBV
$443B
$2.72M 2.08%
30,580
– –
CVX icon
10
Chevron
CVX
$392B
$2.57M 1.96%
21,868
-338
-2% -$36.9K
V icon
11
Visa
V
$684B
$2.15M 1.65%
20,480
-600
-3% -$60.9K
PFE icon
12
Pfizer
PFE
$143B
$2.15M 1.65%
63,569
– –
FDX icon
13
FedEx
FDX
$72.7B
$1.95M 1.49%
8,660
– –
NVS icon
14
Novartis
NVS
$297B
$1.86M 1.42%
24,161
– –
GE icon
15
GE Aerospace
GE
$374B
$1.85M 1.41%
15,952
-637
-4% -$77K
UNH icon
16
UnitedHealth
UNH
$376B
$1.78M 1.36%
9,115
– –
COST icon
17
Costco
COST
$422B
$1.65M 1.26%
+10,065
New +$1.58M
SBUX icon
18
Starbucks
SBUX
$120B
$1.59M 1.22%
+29,615
New +$1.64M
BLK icon
19
Blackrock
BLK
$169B
$1.55M 1.18%
3,460
– –
ZTS icon
20
Zoetis
ZTS
$32.4B
$1.54M 1.18%
24,190
-800
-3% -$50.1K
DIS icon
21
Walt Disney
DIS
$167B
$1.51M 1.15%
15,302
– –
HBI
22
DELISTED
Hanesbrands
HBI
$1.5M 1.14%
60,695
– –
GOOG icon
23
Alphabet (Google) Class C
GOOG
$4.36T
$1.43M 1.09%
29,380
-2,000
-6% -$93.2K
RDS.B
24
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.39M 1.06%
22,225
– –
AZN icon
25
AstraZeneca
AZN
$263B
$1.27M 0.97%
18,700
– –
1
2

Similar funds

PMLI
Penn Mutual Life Insurance Horsham, Pennsylvania $125M AUM 9.1% 1-Year Est. Return
KFA
Kabarec Financial Advisors Palatine, Illinois $131M AUM
FAM
Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MAI
Marble Arch Investments New York $82.3M AUM 31.35% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
ACM
Altalis Capital Management New York $79.7M AUM 1.72% 1-Year Est. Return

Daniel Devine & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Daniel Devine & Co held 51 positions worth $131M, up 6.7% from $123M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Daniel Devine & Co's Q3 2017 filing shows 4 new, 3 increased, 13 reduced and 2 closed positions. Its largest new stake was Starbucks: 29,615 shares worth $1.59M. The largest sale was Procter & Gamble, an estimated $399K.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Daniel Devine & Co's largest Q3 2017 buy was Starbucks: 29,615 shares worth $1.59M.
  • Daniel Devine & Co added most to iShares Biotechnology ETF in Q3 2017, an estimated $266K increase.
  • Daniel Devine & Co's biggest Q3 2017 reduction was Procter & Gamble, cutting an estimated $399K.
  • Daniel Devine & Co fully exited Plains All American Pipeline in Q3 2017, selling an estimated $231K.
  • Daniel Devine & Co's ten largest holdings make up 69% of its $131M portfolio in Q3 2017.
  • Daniel Devine & Co opened 4 new positions and closed 2 in Q3 2017.
  • Daniel Devine & Co's portfolio value rose 6.7% quarter-over-quarter to $131M.

Based on Daniel Devine & Co's 13F filing for Q3 2017, filed 17 Nov 2017.